2-BUTYL-1,3-THIAZOLE-4-CARBOXYLIC ACID, 95%, 500mg

3-Methyl-3-buten-2-one (stabilized with HQ)>90.0%(GC)25mL

3,5-Di-O-caffeoylquinic acid, 98.0%, 250mg

methyl 3-(3-bromoisoxazol-5-yl)propanoate, 1g

Rebastinib, 99.91%, 5mg

4-bromo-3-(4-fluorophenyl)-1H-pyrazole-5-carboxylic acid, 95.0%, 500mg

3,6-Dichloropyridazine-4-carboxamide, 95.0%, 5g

4-(Pyren-1-yl)butanoic acid, 95.0%, 10g

6-Hydroxyhexahydro-2H-3,5-methanocyclopenta[b]furan-2-one, 95.0%, 5g

ethyl 2-(1-{[1-(2-ethoxy-2-oxoethyl)cyclopropyl]amino}cyclopropyl)acetate, 95.0%, 250mg

3-Bromo-5,6-dimethyl-2(1H)pyridinone, 95.0%, 250mg

Methyl 6-chloro-3-methylpyrazine-2-carboxylate, 97%, 1g

4-Amino-3-nitrophenol>97.0%(T)25g